Watson Didn't Infringe Mucinex Patent: Fed. Circ.
The Federal Circuit on Thursday affirmed that Watson Laboratories Inc.'s generic version of congestion reliever Mucinex did not infringe a Reckitt Benckiser Inc. patent....To view the full article, register now.
Already a subscriber? Click here to view full article